Severe falls among older adults with resected stage II/III colon cancer receiving chemotherapy.

被引：0
|
作者：
LoConte, Noelle K.
Allen, Glenn
Leal, Ticiana A. B.
Weiss, Jennifer
Neuman, Heather B.
Greenblatt, David Y.
Schmacher, Jessica
Gayle, Arlene Angela
O'Connor, Erin S.
Smith, Maureen
机构：
[1] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA
[2] Univ Wisconsin, Madison, WI USA
[3] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14550
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Duration of oxaliplatin-based adjuvant chemotherapy in patients with Stage III or high-risk Stage II resected colon cancer
    Moretto, Roberto
    Falcone, Alfredo
    Cremolini, Chiara
    INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (09) : 2652 - 2654
  • [22] Pilot study of a measure of functional dependence in older adults receiving chemotherapy.
    Goodwin, J
    Coleman, EA
    ONCOLOGY NURSING FORUM, 2005, 32 (01) : 159 - 159
  • [23] Use of chemotherapy and mismatch repair deficiency testing in resected stage II colon cancer
    Au, L.
    Grant, M.
    Haydon, A.
    Oliva, K.
    Wilkins, S.
    Segelov, E.
    Antill, Y.
    Peter, C.
    Ranchod, P.
    Polglase, A.
    Chin, M.
    Chip, F.
    Skinner, S.
    Roger, W.
    McMurrick, P.
    Shapiro, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [24] The role of adjuvant chemotherapy in stage II and III mucinous colon cancer
    Fields, Adam C.
    Lu, Pamela
    Goldberg, Joel
    Irani, Jennifer
    Bleday, Ronald
    Melnitchouk, Nelya
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (07) : 1190 - 1200
  • [25] Predictors of Unplanned Hospitalizations Among Older Adults Receiving Cancer Chemotherapy
    Klepin, Heidi D.
    Sun, Can-Lan
    Smith, David D.
    Elias, Rawad
    Trevino, Kelly M.
    Bryant, Ashley Leak
    Li, Daneng
    Nelson, Christian
    Tew, William P.
    Mohile, Supriya G.
    Gajra, Ajeet
    Owusu, Cynthia
    Gross, Cary
    Lichtman, Stuart M.
    Katheria, Vani V.
    Muss, Hyman B.
    Chapman, Andrew E.
    Cohen, Harvey Jay
    Hurria, Arti
    Dale, William
    JCO ONCOLOGY PRACTICE, 2021, 17 (06) : E740 - E752
  • [26] Rate of Peritoneal Carcinomatosis in Surgically-Resected Stage II and III Colon Cancer
    Choi, A.
    Kejriwal, N.
    Calidas, A.
    Cordero-Caban, K.
    Kwong, M. M.
    Selleck, M.
    Senthil, M.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S116 - S116
  • [27] FOLFOX and FLOX Regimens for the Adjuvant Treatment of Resected Stage II and III Colon Cancer
    Sharif, Saima
    O'Connell, Michael J.
    Yothers, Greg
    Lopa, Samia
    Wolmark, Norman
    CANCER INVESTIGATION, 2008, 26 (09) : 956 - 963
  • [28] Prognosis of mucinous histology for patients with radically resected stage II and III colon cancer
    Catalano, V.
    Loupakis, F.
    Graziano, F.
    Bisonni, R.
    Torresi, U.
    Vincenzi, B.
    Mari, D.
    Giordani, P.
    Alessandroni, P.
    Salvatore, L.
    Fornaro, L.
    Santini, D.
    Baldelli, A. M.
    Rossi, D.
    Giustini, L.
    Silva, R. R.
    Falcone, A.
    D'Emidio, S.
    Rocchi, M.
    Fedeli, S. Luzi
    ANNALS OF ONCOLOGY, 2012, 23 (01) : 135 - U111
  • [29] PROGNOSIS OF MUCINOUS HISTOLOGY FOR PATIENTS WITH RADICALLY RESECTED STAGE II AND III COLON CANCER
    Catalano, V
    Loupakis, F.
    Bisonni, R.
    Torresi, U.
    Vincenzi, B.
    Mari, D.
    Giordani, P.
    Baldi, G.
    Santini, D.
    Giustini, L.
    Silva, R.
    Falcone, A.
    D'Emidio, S.
    Rocchi, M.
    Graziano, F.
    ANNALS OF ONCOLOGY, 2009, 20 : 61 - 61
  • [30] PROGNOSIS OF MUCINOUS HISTOLOGY FOR PATIENTS WITH RADICALLY RESECTED STAGE II AND III COLON CANCER
    Catalano, V
    Loupakis, F.
    Graziano, F.
    Bisonni, R.
    Torresi, U.
    Vincenzi, B.
    Mari, D.
    Giordani, P.
    Baldi, G.
    Santini, D.
    Giustini, L.
    Silva, R. R.
    Falcone, A.
    D'Emidio, S.
    Rocchi, M.
    Fedeli, Luzi S.
    ANNALS OF ONCOLOGY, 2009, 20
12345